PHLN laboratory procedures and precautions for samples collected from patients with viral haemorrhagic fevers

These procedures explain how laboratories should collect and handle samples from patients with suspected viral haemorrhagic fevers.


Part A

Part B

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Publication type:
Health sector

The viral haemorrhagic fevers group of diseases comprises Lassa fever, Congo-Crimean haemorrhagic fever, Ebola and Marburg virus infections.

These guidelines are presented in 2 parts: 

  • Part A: Guidelines for laboratories that are not associated with a designated isolation hospital
  • Part B: Guidelines for laboratories that are associated with a designated isolation hospital

Help us improve

If you would like a response please use the enquiries form instead.